We love to hear from our listeners. Send us a message.

Back by popular demand, biopharma industry opinionator extraordinaire Allan Shaw rejoins the Business of Biotech to expose the murky role Pharmacy Benefit Managers (PBMs) play in the last, costly mile of the drug distribution supply chain. Allan pulls no punches in his criticism of the current rebate structure and shares why the model leaves patients and manufacturers stuck with the spiraling tab. He also explains why an election year, all-time lows in public perception of the pharmaceutical industry, and inflation might create the perfect storm for real change. More than a gripe session, Allan offers up advice for biotech leaders entering the fray, shares his own ideas for systemic reform that would reward patients, not PBMs, and waxes on what, and who, it might take to change the broken paradigm.

Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.

Subscribe to our monthly Business of Biotech newsletter.

Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com

Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

Quick Questions w/ Tony Ruggiero